These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18272513)

  • 1. Oral therapy with sertraline, a selective serotonin reuptake inhibitor, shows activity against Leishmania donovani.
    Palit P; Ali N
    J Antimicrob Chemother; 2008 May; 61(5):1120-4. PubMed ID: 18272513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sertraline Delivered in Phosphatidylserine Liposomes Is Effective in an Experimental Model of Visceral Leishmaniasis.
    Romanelli MM; da Costa-Silva TA; Cunha-Junior E; Dias Ferreira D; Guerra JM; Galisteo AJ; Pinto EG; Barbosa LRS; Torres-Santos EC; Tempone AG
    Front Cell Infect Microbiol; 2019; 9():353. PubMed ID: 31737574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP1 human acute monocytic leukemia cell line.
    Jain SK; Sahu R; Walker LA; Tekwani BL
    J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.
    Vishwakarma P; Parmar N; Yadav PK; Chandrakar P; Kar S
    J Mol Med (Berl); 2016 Jun; 94(6):695-710. PubMed ID: 26830627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indolylquinoline derivatives are cytotoxic to Leishmania donovani promastigotes and amastigotes in vitro and are effective in treating murine visceral leishmaniasis.
    Chakrabarti G; Basu A; Manna PP; Mahato SB; Mandal NB; Bandyopadhyay S
    J Antimicrob Chemother; 1999 Mar; 43(3):359-66. PubMed ID: 10223591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asiaticoside induces tumour-necrosis-factor-α-mediated nitric oxide production to cure experimental visceral leishmaniasis caused by antimony-susceptible and -resistant Leishmania donovani strains.
    Bhaumik SK; Paul J; Naskar K; Karmakar S; De T
    J Antimicrob Chemother; 2012 Apr; 67(4):910-20. PubMed ID: 22258930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
    Charan Raja MR; Velappan AB; Chellappan D; Debnath J; Kar Mahapatra S
    Eur J Med Chem; 2017 Oct; 139():503-518. PubMed ID: 28826085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral activity of the antimalarial endoperoxide 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol (N-251) against Leishmania donovani complex.
    Kwofie KD; Sato K; Sanjoba C; Hino A; Shimogawara R; Amoa-Bosompem M; Ayi I; Boakye DA; Anang AK; Chang KS; Ohashi M; Kim HS; Ohta N; Matsumoto Y; Iwanaga S
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007235. PubMed ID: 30908481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis.
    Gupta S; Yardley V; Vishwakarma P; Shivahare R; Sharma B; Launay D; Martin D; Puri SK
    J Antimicrob Chemother; 2015 Feb; 70(2):518-27. PubMed ID: 25389223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
    Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
    Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Amino acid derivatives as mitochondrial complex III inhibitors of L. donovani: A promising chemotype targeting visceral leishmaniasis.
    Chandrakar P; Gunaganti N; Parmar N; Kumar A; Singh SK; Rashid M; Wahajuddin M; Mitra K; Narender T; Kar S
    Eur J Med Chem; 2019 Nov; 182():111632. PubMed ID: 31499363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani.
    Sinha R; Roychoudhury J; Palit P; Ali N
    Antimicrob Agents Chemother; 2015 Jan; 59(1):344-55. PubMed ID: 25367907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of synergy between host and pathogen-directed therapies against intracellular Leishmania donovani.
    Zahid MSH; Johnson MM; Tokarski RJ; Satoskar AR; Fuchs JR; Bachelder EM; Ainslie KM
    Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():125-132. PubMed ID: 31493763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo antileishmanial efficacy of nitazoxanide against Leishmania donovani.
    Zhang R; Shang L; Jin H; Ma C; Wu Y; Liu Q; Xia Z; Wei F; Zhu XQ; Gao H
    Parasitol Res; 2010 Jul; 107(2):475-9. PubMed ID: 20495931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of a novel sulfonamide compound 2-nitro-N-(pyridin-2-ylmethyl)benzenesulfonamide against Leishmania donovani.
    Dikhit MR; Purkait B; Singh R; Sahoo BR; Kumar A; Kar RK; Ansari MY; Saini S; Abhishek K; Sahoo GC; Das S; Das P
    Drug Des Devel Ther; 2016; 10():1753-61. PubMed ID: 27307706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel arylimidamides for treatment of visceral leishmaniasis.
    Wang MZ; Zhu X; Srivastava A; Liu Q; Sweat JM; Pandharkar T; Stephens CE; Riccio E; Parman T; Munde M; Mandal S; Madhubala R; Tidwell RR; Wilson WD; Boykin DW; Hall JE; Kyle DE; Werbovetz KA
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2507-16. PubMed ID: 20368397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorogenic acid acts upon Leishmania donovani arresting cell cycle and modulating cytokines and nitric oxide in vitro.
    Majumder N; Ganguly S; Ghosh AK; Kundu S; Banerjee A; Saha S
    Parasite Immunol; 2020 Jun; 42(6):e12719. PubMed ID: 32248547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania.
    Chen M; Christensen SB; Blom J; Lemmich E; Nadelmann L; Fich K; Theander TG; Kharazmi A
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2550-6. PubMed ID: 8109916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the antileishmanial potency, toxicity and phytochemical constituents of methanol bark extract of Sterculia villosa.
    Das A; Das MC; Das N; Bhattacharjee S
    Pharm Biol; 2017 Dec; 55(1):998-1009. PubMed ID: 28173714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani.
    Corpas-Lopez V; Moniz S; Thomas M; Wall RJ; Torrie LS; Zander-Dinse D; Tinti M; Brand S; Stojanovski L; Manthri S; Hallyburton I; Zuccotto F; Wyatt PG; De Rycker M; Horn D; Ferguson MAJ; Clos J; Read KD; Fairlamb AH; Gilbert IH; Wyllie S
    ACS Infect Dis; 2019 Jan; 5(1):111-122. PubMed ID: 30380837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.